{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T03:21:39Z","timestamp":1764645699647,"version":"3.41.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Proton pump inhibitors (PPIs) are one of the most commonly prescribed drugs worldwide and have changed the treatment of gastroesophageal reflux disease (GERD). However, these drugs have been associated with several potentially serious adverse reactions if used chronically. Guidelines from the American College of Gastroenterology in 2021 and the American Gastroenterological Association's 2022 clinical practice updates reflect the latest recommendations. This article reviews the management and treatment of GERD and the adverse reactions to long-term PPI use.<\/jats:p>","DOI":"10.1097\/01.jaa.0000991384.08967.0d","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T23:00:43Z","timestamp":1700607643000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Gastroesophageal reflux disease management and chronic use of proton pump inhibitors"],"prefix":"10.1097","volume":"36","author":[{"given":"Anne M.","family":"Howland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250605","first-page":"1","article-title":"Gastroesophageal reflux disease and complications","author":"Ravindran","year":"2020","journal-title":"Geriatric Gastroenterology"},{"issue":"3","key":"R2-20250605","first-page":"214","article-title":"Gastroesophageal reflux disease (GERD)","volume":"115","author":"Clarrett","year":"2018","journal-title":"Mo Med"},{"author":"Kahrilas","key":"R3-20250605","article-title":"Clinical manifestations and diagnosis of gastroesophageal reflux in adults"},{"issue":"2","key":"R4-20250605","first-page":"1","article-title":"The natural history of gastro-esophageal reflux disease: a comprehensive review","volume":"30","author":"Savarino","year":"2017","journal-title":"Dis Esophagus"},{"issue":"4","key":"R5-20250605","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2008.08.045","article-title":"American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"R6-20250605","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"R7-20250605","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.gastro.2017.07.045","article-title":"Presentation and epidemiology of gastroesophageal reflux disease","volume":"154","author":"Richter","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"R8-20250605","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cgh.2022.01.025","article-title":"AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review","volume":"20","author":"Yadlapati","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-3-030-27592-1_14","article-title":"Medical treatment of GERD","author":"Muller","year":"2020","journal-title":"Foregut Surgery: Achalasia, Gastroesophageal Reflux Disease and Obesity"},{"issue":"1","key":"R10-20250605","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease","volume":"117","author":"Katz","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"R11-20250605","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ajg.2013.414","article-title":"Tobacco smoking cessation and improved gastroesophageal reflux: a prospective population-based cohort study: the HUNT study","volume":"109","author":"Ness-Jensen","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"R12-20250605","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bpg.2017.09.004","article-title":"Tobacco smoking, alcohol consumption and gastro-oesophageal reflux disease","volume":"31","author":"Ness-Jensen","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"12","key":"R13-20250605","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1007\/s10620-017-4830-5","article-title":"Recent advances in the pharmacological management of gastroesophageal reflux disease","volume":"62","author":"Kung","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"1","key":"R14-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11938-017-0115-5","article-title":"Clinical implications of emerging data on the safety of proton pump inhibitors","volume":"15","author":"Schnoll-Sussman","year":"2017","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"4","key":"R15-20250605","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2021.12.247","article-title":"AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review","volume":"162","author":"Targownik","year":"2022","journal-title":"Gastroenterology"},{"issue":"2","key":"R16-20250605","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.giec.2019.12.005","article-title":"Proton pump inhibitors: the good, bad, and ugly","volume":"30","author":"Schnoll-Sussman","year":"2020","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"7","key":"R17-20250605","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ajg.2016.156","article-title":"Long-term PPI use: balancing potential harms and documented benefits","volume":"111","author":"Laine","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"R18-20250605","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"issue":"6","key":"R19-20250605","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/MOG.0000000000000580","article-title":"Proton pump inhibitors: placing putative adverse effects in proper perspective","volume":"35","author":"Schubert","year":"2019","journal-title":"Curr Opin Gastroenterol"},{"issue":"10124","key":"R20-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/JAMMR\/2017\/34805","article-title":"Micronutrient consequences of long term proton pump inhibitor therapy","volume":"22","author":"Inayet","year":"2017","journal-title":"J Adv Med Med Res"},{"issue":"1","key":"R21-20250605","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00198-018-4788-y","article-title":"Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies","volume":"30","author":"Poly","year":"2019","journal-title":"Osteoporos Int"},{"issue":"1","key":"R22-20250605","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ajg.2016.481","article-title":"Long-term proton pump inhibitor use is not associated with changes in bone strength and structure","volume":"112","author":"Targownik","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"R23-20250605","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrgastro.2017.117","article-title":"Proton-pump inhibitors: understanding the complications and risks","volume":"14","author":"Malfertheiner","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"20","key":"R24-20250605","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"R25-20250605","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","article-title":"Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin","volume":"157","author":"Moayyedi","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"R26-20250605","first-page":"38","article-title":"Small intestinal bacterial overgrowth (SIBO): result of altered defensive mechanism in gastrointestinal--a review","volume":"21","author":"Kurniawan","year":"2020","journal-title":"Indones J Gastroenterol Hepatol Dig Endosc"},{"author":"Pimentel","key":"R27-20250605","article-title":"Small intestinal bacterial overgrowth: clinical manifestations and diagnosis"},{"issue":"8","key":"R28-20250605","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/jgh.13750","article-title":"Dementia, cognitive impairment and proton pump inhibitor therapy: a systematic review","volume":"32","author":"Batchelor","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"R29-20250605","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/jgs.15073","article-title":"Proton pump inhibitor use and dementia risk: prospective population-based study","volume":"66","author":"Gray","year":"2018","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"R30-20250605","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/jgs.14956","article-title":"Proton pump inhibitors and risk of mild cognitive impairment and dementia","volume":"65","author":"Goldstein","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"R31-20250605","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.gastro.2017.04.047","article-title":"Complications of proton pump inhibitor therapy","volume":"153","author":"Vaezi","year":"2017","journal-title":"Gastroenterology"},{"issue":"6","key":"R32-20250605","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/MCG.0000000000001035","article-title":"The association between proton pump inhibitor use with acute kidney injury and chronic kidney disease","volume":"52","author":"Kamal","year":"2018","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"R33-20250605","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/phar.2235","article-title":"Proton pump inhibitors and risk of acute and chronic kidney disease: a retrospective cohort study","volume":"39","author":"Hart","year":"2019","journal-title":"Pharmacotherapy"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000991384.08967.0d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T20:05:09Z","timestamp":1749153909000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000991384.08967.0d"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000991384.08967.0d","relation":{},"ISSN":["1547-1896"],"issn-type":[{"type":"print","value":"1547-1896"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}